NANO-X (NNOX) Rockets 26.4% as $15M Raise Fuels AI Expansion *Dynamic verb "Rockets" and metaphor "AI Expansion" capture momentum; includes precise percentage and causal funding detail. Meets 12-word limit with professional clarity.*

NANO-X IMAGING (NNOX) surged 26.3768% in pre-market trading on November 24, 2025, following the announcement of a $15 million registered direct offering to fuel growth initiatives. The medical imaging firm secured 3,826,530 ordinary shares from a single institutional investor, with proceeds earmarked for working capital, AI infrastructure, and market expansion. CEO Erez Meltzer emphasized the move would accelerate technological advancements and strengthen the company’s balance sheet.

The offering, led by Titan Partners Group as sole placement agent, is structured under an effective SEC registration statement. Investors cited the transaction as a strategic step to enhance Nanox’s ability to scale its AI-driven imaging solutions and teleradiology services. The closing is expected by November 25, 2025, pending standard conditions.

Analysts noted the raise addresses liquidity needs while aligning with long-term goals to expand access to affordable diagnostics. The pre-market rally reflects optimism over the capital infusion’s potential to support R&D and operational scaling, though market volatility remains a factor amid broader economic uncertainties.

Backtest Assumption: A hypothetical strategy targeting NNOX’s recent momentum could leverage its pre-market surge and capital raise news. A long position initiated at the open of November 24, 2025, with a stop-loss at 15% below entry, would aim to capture gains from the announced financing’s market validation. Performance would depend on post-announcement volume and broader sector trends.